HK1258800A1 - 用於修復心臟組織的心外膜衍生的旁分泌因子 - Google Patents

用於修復心臟組織的心外膜衍生的旁分泌因子

Info

Publication number
HK1258800A1
HK1258800A1 HK19101164.7A HK19101164A HK1258800A1 HK 1258800 A1 HK1258800 A1 HK 1258800A1 HK 19101164 A HK19101164 A HK 19101164A HK 1258800 A1 HK1258800 A1 HK 1258800A1
Authority
HK
Hong Kong
Prior art keywords
epicardial
cardiac tissue
paracrine factors
repairing cardiac
derived paracrine
Prior art date
Application number
HK19101164.7A
Other languages
English (en)
Inventor
P‧魯伊斯-洛扎諾
M．莫克拉
K．魏
Original Assignee
雷根科公司
桑福德伯納姆普雷比斯醫學研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 雷根科公司, 桑福德伯納姆普雷比斯醫學研究所 filed Critical 雷根科公司
Publication of HK1258800A1 publication Critical patent/HK1258800A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
HK19101164.7A 2015-04-09 2019-01-23 用於修復心臟組織的心外膜衍生的旁分泌因子 HK1258800A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562145480P 2015-04-09 2015-04-09
US201562196766P 2015-07-24 2015-07-24
PCT/US2016/026809 WO2016164840A1 (en) 2015-04-09 2016-04-08 Epicardial-derived paracrine factors for repairing cardiac tissue

Publications (1)

Publication Number Publication Date
HK1258800A1 true HK1258800A1 (zh) 2019-11-22

Family

ID=57072385

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19101164.7A HK1258800A1 (zh) 2015-04-09 2019-01-23 用於修復心臟組織的心外膜衍生的旁分泌因子

Country Status (10)

Country Link
US (2) US10682416B2 (zh)
EP (2) EP3280429B1 (zh)
JP (3) JP6839393B2 (zh)
CN (2) CN115417921A (zh)
AU (3) AU2016246070B2 (zh)
CA (1) CA2982179A1 (zh)
DK (1) DK3280429T3 (zh)
ES (1) ES2927176T3 (zh)
HK (1) HK1258800A1 (zh)
WO (1) WO2016164840A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3280429B1 (en) * 2015-04-09 2022-06-01 Regencor, Inc. Fstl1 for use in repairing cardiac tissue
CN108486046B (zh) * 2018-02-09 2020-09-25 苏州大学 一种抗缺氧损伤的干细胞制剂及其制备方法与在制备治疗急性心梗药物中的应用
WO2023183933A1 (en) * 2022-03-25 2023-09-28 Regencor, Inc. Use of follistatin-like 1 (fstl1) in cardiometabolic heart failure
WO2023210713A1 (ja) * 2022-04-27 2023-11-02 国立大学法人京都大学 心外膜細胞再生促進剤および心外膜細胞の再生促進方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253644A1 (en) * 1995-11-07 2004-12-16 Kaneka Corporation Rheumatoid arthritis autoantigen polypeptides
GB0611845D0 (en) * 2006-06-15 2006-07-26 Mcinerney Joseph G The utility hydration system
WO2009052478A1 (en) * 2007-10-19 2009-04-23 Trustees Of Boston University Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide
US20090326053A1 (en) * 2008-05-30 2009-12-31 Trustees Of Boston University Diagnostic uses of follistatin-like 1
US20100330044A1 (en) 2009-06-30 2010-12-30 Universite Libre De Bruxelles Mesp1 as a master regulator of multipotent cardiovascular progenitor specification and uses thereof
US20110104735A1 (en) 2009-11-01 2011-05-05 Zenbio, Inc. Human omental mesothelial cells, methods of isolation and uses thereof
WO2012019099A2 (en) 2010-08-05 2012-02-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Follistatin-like-protein-1 as a biomarker for inflammatory disorders
CA2814713A1 (en) 2010-10-14 2012-04-19 University Of Central Florida Research Foundation, Inc. Cardiac induced pluripotent stem cells and methods of use in repair and regeneration of myocardium
CN102648977B (zh) * 2011-02-25 2014-12-10 中国科学院上海生命科学研究院 滤泡素抑制素样蛋白1在调节钠钾atp酶活性中的用途
EP3280429B1 (en) * 2015-04-09 2022-06-01 Regencor, Inc. Fstl1 for use in repairing cardiac tissue

Also Published As

Publication number Publication date
DK3280429T3 (da) 2022-08-29
US20180092980A1 (en) 2018-04-05
ES2927176T3 (es) 2022-11-03
CN108601810B (zh) 2022-07-05
EP3280429A4 (en) 2018-12-19
AU2023214306A1 (en) 2023-08-31
CN108601810A (zh) 2018-09-28
JP2021046441A (ja) 2021-03-25
AU2020204541A1 (en) 2020-07-30
US10682416B2 (en) 2020-06-16
JP2023018119A (ja) 2023-02-07
EP4088733A1 (en) 2022-11-16
CN115417921A (zh) 2022-12-02
EP3280429A1 (en) 2018-02-14
JP2018512456A (ja) 2018-05-17
JP6839393B2 (ja) 2021-03-10
CA2982179A1 (en) 2016-10-13
JP7190711B2 (ja) 2022-12-16
AU2016246070A1 (en) 2017-11-02
AU2016246070B2 (en) 2020-04-09
WO2016164840A1 (en) 2016-10-13
US20200345851A1 (en) 2020-11-05
AU2020204541B2 (en) 2023-05-18
EP3280429B1 (en) 2022-06-01

Similar Documents

Publication Publication Date Title
EP3364916C0 (en) MEDICAL IMPLANT FOR HEART VALVE REPAIR
GB2531994B (en) Surgical articulation
GB2530487B (en) Device for heart repair
SG10201913800UA (en) Patient interfaces
SG11201608616VA (en) Patient interfaces
GB2546055B (en) Patient reference tool
SG10202102729UA (en) Patient interfaces
EP3378053C0 (en) SIMULATED DISSECTABLE TISSUE
IL250181B2 (en) Pulmonary artery graft
HK1245159A1 (zh) 脫細胞化組織
HK1245066A1 (zh) 眼科手術裝置
GB2543540B (en) Decellularising tissue
HK1258800A1 (zh) 用於修復心臟組織的心外膜衍生的旁分泌因子
EP3531936C0 (en) RETRACTABLE FORCEPS
EP3374495A4 (en) IMPROVED METHODS OF FABRICATING FABRICS
GB201622416D0 (en) Tissue scaffold
IL247914A0 (en) implant connection
GB201514303D0 (en) Bifidobacteria for treating cardiac conditions
GB201513097D0 (en) Medical implant
GB201502647D0 (en) Medical implant
SG10202008024VA (en) Method for Treating Heart Failure
EP3509652C0 (fr) Biomateriau a usage therapeutique
HK1231364A1 (zh) 外科手術用海綿
GB201517096D0 (en) Surgical aid
GB201510481D0 (en) Artificial heart